| 1 |
25952464 | Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study. | 2015 Aug |
1 |
| 2 |
21791475 | Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia. | 2011 Nov |
2 |
| 3 |
18927314 | A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors. | 2008 Oct 15 |
2 |
| 4 |
15699047 | The role of checkpoint kinase 1 in sensitivity to topoisomerase I poisons. | 2005 Apr 8 |
1 |
| 5 |
15784732 | Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine. | 2005 Jul 1 |
1 |
| 6 |
14570880 | Hsp90 inhibition depletes Chk1 and sensitizes tumor cells to replication stress. | 2003 Dec 26 |
11 |